Cargando…
Immuno-oncology therapy associated thromboembolic events in metastatic renal cell carcinoma
The relationship between thromboembolic events (TEs) and immune-oncology (IO) agents in patients with metastatic renal cell carcinoma (mRCC) with inferior-vena-cava (IVC) thrombus has not been explored despite conferring significant morbidity. A late 30s female is diagnosed with mRCC with a level-II...
Autores principales: | Alhamdani, Zein, Alberto, Matthew, Ischia, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199195/ https://www.ncbi.nlm.nih.gov/pubmed/37215941 http://dx.doi.org/10.1016/j.eucr.2023.102420 |
Ejemplares similares
-
Immuno-Oncology: Emerging Targets and Combination Therapies
por: Marshall, Henry T., et al.
Publicado: (2018) -
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
por: Navani, Vishal, et al.
Publicado: (2022) -
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
por: Kamta, Jeff, et al.
Publicado: (2017) -
The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019) -
Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)